| Literature DB >> 27965302 |
Pepijn Huizinga1,2, Marjolein Kluytmans- van den Bergh3,4, Miranda van Rijen1, Ina Willemsen1, Nils van 't Veer5, Jan Kluytmans1,4.
Abstract
In this cross-sectional study, 8.5% of patients using proton pump inhibitors (PPIs) were rectal carriers of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E), compared with 2.9% of non-PPI users. In multivariable analysis, PPI use was independently associated with ESBL-E rectal carriage at hospital admission (adjusted odds ratio, 3.89; 95% confidence interval, 1.65 - 9.19).Entities:
Keywords: ESBL; carriage; proton pump inhibitor; risk factor.
Mesh:
Substances:
Year: 2016 PMID: 27965302 DOI: 10.1093/cid/ciw743
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079